Pricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Pretax margin (%)

AFC-HD AMS Life Science Co.,Ltd.【JP:2927】

Market cap
¥12.7B
P/E ratio
8.5x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Aug 31, 20257.5+17.58%
Aug 31, 20246.4-1.57%
Aug 31, 20236.5+10.72%
Aug 31, 20225.8-39.57%
Aug 31, 20219.7+39.02%
Aug 31, 20207+11.34%
Aug 31, 20196.2+0.44%
Aug 31, 20186.2-9.52%
Aug 31, 20176.9+23.75%
Aug 31, 20165.6-10.28%
Aug 31, 20156.2+67.32%
Aug 31, 20143.7-35.07%
Aug 31, 20135.7+25.05%
Aug 31, 20124.6-32.99%
Aug 31, 20116.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)